Researchers note that further studies would help more definitively determine overall safety for breastfeeding patients and their babies, which aligns with the overall consensus over semaglutide and other glucagon-like peptide-1 (GLP-1) receptor agonists, which are not currently advised for use during pregnancy or while nursing
They exclusively provide compounded products containing semaglutide base, akin to Ozempic and Wegovy
Insurance coverage for Zepbound varies by plan
(Learn more about Part D.) Typically, the private insurance companies that sell Part D plans to Medicare recipients cover the costs of medications for Part D recipients, but the Bridge program is unique
Therefore, there is an urgent need for new antimalarial medicines to complement the existing first-line artemisinin-based combination therapies
The most affordable option is Zepbound vials and multi-dose pens through Lilly Direct, starting at $299 for the 2.5 mg dose